相关实验视频
Updated: Sep 17, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.4K
在慢性病中非动脉样硬化性心血管疾病 慢性病
Nishigandha Pradhan1, Mirela Dobre1
1Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Cardiology clinics
|June 29, 2025
概括
慢性病 (CKD) 中的非动脉硬性心血管疾病 (CVD) 涉及动脉加厚和纤维化. 特定于CKD的因素加剧了诸如左心室缩和心力衰竭等疾病,增加了死亡率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 病理生理学 病理生理学
背景情况:
- 非动脉硬性心血管疾病 (CVD) 在慢性病 (CKD) 中很常见.
- 独特的病理生理机制驱动CKD患者的心血管疾病.
- 动脉样硬化,以中枢动脉加厚和纤维化为标志,是其关键特征.
研究的目的:
- 阐明CKD中非动脉硬性心血管疾病的机制和临床表现.
- 突出骨矿物代谢失调在动脉硬和化中的作用.
- 为了确定加剧心血管并发症的CKD特异性因素.
主要方法:
- 对CKD和CVD相关联的病理生理机制的审查.
- 分析临床表现及其在晚期CKD中的患病率.
- 确定有助于CKD的特定因素.
主要成果:
- 在CKD中非动脉硬性心血管疾病涉及中枢动脉加厚,纤维化和骨矿物代谢失调.
- 临床表现包括左心室缩 (晚期CKD的70-80%),心力衰竭,膜心脏病和心律失常.
- 诸如体积过载,贫血和交感性过度活动等CKD因素会使结果恶化.
结论:
- 非动脉硬性心血管疾病是CKD的一个重要并发症,具有独特的驱动因素.
- 了解这些机制对于控制慢性病患者心血管风险至关重要.
- 解决CKD特异性因素对于减少心血管疾病发病率和死亡率至关重要.
相关概念视频
Chronic Kidney Disease I: Introduction
76
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
76
Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Chronic Kidney Disease IV: Nursing Management
60
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
60
Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Acute Kidney Injury IV: Diagnostic Studies and Prevention
59
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
59
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524

